HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Irie, T. Articles by Kawai, A. Search for Related Content PubMed PubMed Citation Articles by Irie, T. Articles by Kawai, A. Agricola Articles by Irie, T. Articles by Kawai, A.

Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9

Department of Molecular Microbiology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan¹

Author for correspondence: Akihiko Kawai. Fax +81 75 761 2698. e-mail akawai{at}pharm.kyoto-u.ac.jp

Virus-neutralizing activity of two monoclonal antibodies (mAbs), #7-1-9 and #1-46-12, against rabies virus glycoprotein (G) was compared. Although these mAbs affected the virion’s ability to bind to host cells similarly, a big difference was found in the titres of virus neutralization (1:7132 and 1:32 for mAbs #1-46-12 and #7-1-9, respectively, at a concentration of 10 µg protein/ml). Although no big difference in virion-binding affinity between the two mAbs was found, the number of antibodies required for virus neutralization was very low, 20 molecules for mAb #1-46-12 and 250 molecules for mAb #7-1-9. In the latter case, the mAbs cover a major part of the virion surface and cause steric hindrance of viral receptor-binding activity. The infectivity of an epitope-preserved escape mutant virus (R-61) was not affected by the binding of high numbers of mAb #1-46-12 to the virion, which implies that mAb binding does not mask the receptor-binding site of the viral spikes. Based on these results, it is hypothesized that mAb #1-46-12 affected virus infectivity by a mechanism different from covering the virion spikes. Possible virus-neutralizing mechanisms by low numbers of mAb #1-46-12 in comparison to that of mAb #7-1-9 are discussed.

This article has been cited by other articles:

				R. Hernandez, A. Paredes, and D. T. Brown Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal Antibody J. Virol., June 15, 2008; 82(12): 5750 - 5760. [Abstract] [Full Text] [PDF]

				S. K. Lakhashe, M. R. Thakar, K. E. Bharucha, and R. S. Paranjape Quantitation of HLA Proteins Incorporated by Human Immunodeficiency Virus Type 1 and Assessment of Neutralizing Activity of Anti-HLA Antibodies J. Virol., January 1, 2008; 82(1): 428 - 434. [Abstract] [Full Text] [PDF]

				A. B. H. Bakker, W. E. Marissen, R. A. Kramer, A. B. Rice, W. C. Weldon, M. Niezgoda, C. A. Hanlon, S. Thijsse, H. H. J. Backus, J. de Kruif, et al. Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants J. Virol., July 15, 2005; 79(14): 9062 - 9068. [Abstract] [Full Text] [PDF]